Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0003226
UniProt IDQ16739
Primary gene name(s)UGCG
Synonym gene name(s)unknown
Protein nameCeramide glucosyltransferase
Protein functionCatalyzes the first glycosylation step in glycosphingolipid biosynthesis, the transfer of glucose to ceramide. May also serve as a ""flippase"". {ECO:0000269|PubMed:8643456}."
Subcellular locationGolgi apparatus membrane {ECO:0000250};
Multi-pass membrane protein {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q16739
Gene Ontology
(Biological Process)
Complete annatation
epidermis development [GO:0008544];
glucosylceramide biosynthetic process [GO:0006679];
glycosphingolipid biosynthetic process [GO:0006688];
glycosphingolipid metabolic process [GO:0006687];
positive regulation of protein targeting to mitochondrion [GO:1903955]
Gene Ontology
(Molecular Function)
Complete annatation
ceramide glucosyltransferase activity [GO:0008120]
Gene Ontology
(Cellular Component)
Complete annatation
Golgi membrane [GO:0000139];
integral component of membrane [GO:0016021];
membrane [GO:0016020]
Protein-protein interaction113204
Phylogenetic treeQ16739
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.717995223121740.0297934650822940.0647041939078292
AZA vs. DISU0.03402690083562810.8934504584728340.993789282048992
AZA vs. IL70.3124489158063280.136646844738560.899815592286727
AZA vs. SAHA0.2107405116873530.3951126523417650.756500459977107
DISU vs. CD3-0.6965470516346670.05726522394675790.120475304239267
DISU vs. IL70.2701937627762510.285389896968730.672783232677892
DISU vs. SAHA0.1767570761015850.5472661497823960.85023026413968
DMSO vs. AZA-0.1056161627263720.5337882720510731
DMSO vs. CD3-0.8362871236706510.009606335601004880.0240764760269854
DMSO vs. DISU-0.1417148007311280.5633717332672480.927160862764817
DMSO vs. IL70.4253501905389960.01969423077544650.288997021450832
DMSO vs. SAHA0.3085545292755980.1939939021497320.530710128752698
HIV vs. Mock in Activation-0.09416825657949850.8802543728279710.999983755607037
HIV vs. Mock in Latency-0.06638430469041260.6890881199014580.999834320637052
IL7 vs. CD3-0.3959087640775510.2204250440239330.34733624660398
SAHA vs. CD3-0.5342088038709020.1316178556322780.217034805162319
SAHA vs. IL7-0.1065778270070960.69721648334890.859419516722652
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
-1.8 0.017183178 -1.8 0.001628723 -1.4 0.17731562
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.211848 0.267507
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB00419 Miglustat approved yes inhibitor
DB05715 Genz-112638 investigational unknown unknown
DB09039 Eliglustat approved yes antagonist

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00600 Sphingolipid metabolism - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
Menu